GYL FINANCIAL SYNERGIES, LLC - SELECT SECTOR SPDR TR ownership

SELECT SECTOR SPDR TR's ticker is XLK and the CUSIP is 81369Y803. A total of 1,568 filers reported holding SELECT SECTOR SPDR TR in Q1 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.7%.

Quarter-by-quarter ownership
GYL FINANCIAL SYNERGIES, LLC ownership history of SELECT SECTOR SPDR TR
ValueSharesWeighting
Q3 2023$3,533,278
-7.9%
21,554
-2.4%
0.34%
-1.7%
Q2 2023$3,837,798
+33.5%
22,074
+15.9%
0.35%
+1.5%
Q1 2023$2,874,920
-28.3%
19,038
-41.0%
0.34%
-60.4%
Q4 2022$4,012,078
-1.4%
32,241
-5.9%
0.87%
-21.7%
Q3 2022$4,069,000
-6.6%
34,260
+0.0%
1.11%
-6.7%
Q2 2022$4,355,000
-20.3%
34,256
-0.4%
1.19%
-9.1%
Q1 2022$5,466,000
+17.0%
34,392
+28.0%
1.31%
+3.8%
Q4 2021$4,671,000
+15.2%
26,863
-1.0%
1.26%
-39.1%
Q3 2021$4,053,000
+0.7%
27,145
-0.4%
2.07%
-0.4%
Q2 2021$4,024,000
+38.1%
27,253
+24.2%
2.08%
+29.6%
Q1 2021$2,914,000
-12.4%
21,938
-14.2%
1.60%
-16.3%
Q4 2020$3,326,000
-3.4%
25,583
-13.3%
1.92%
-15.1%
Q3 2020$3,442,000
+10.0%
29,499
-1.5%
2.26%
-0.4%
Q2 2020$3,129,000
+21.7%
29,943
-6.4%
2.26%
+37.9%
Q1 2020$2,571,000
+64.2%
31,994
+87.3%
1.64%
+137.4%
Q4 2019$1,566,000
+31.9%
17,079
+15.9%
0.69%
+17.3%
Q3 2019$1,187,000
+6.0%
14,737
+2.7%
0.59%
-0.3%
Q2 2019$1,120,000
+3.3%
14,351
-2.0%
0.59%
-2.8%
Q1 2019$1,084,000
-13.3%
14,649
-27.4%
0.61%
-32.9%
Q4 2018$1,251,00020,1880.91%
Other shareholders
SELECT SECTOR SPDR TR shareholders Q1 2022
NameSharesValueWeighting ↓
Thinkbetter Group LLC 194,674$30,083,00030.65%
AGF Investments LLC 1,539,773$229,919,00022.69%
WestEnd Advisors, LLC 2,521,958$376,578,828,00011.33%
Advisors Preferred, LLC 537,338$81,444,00011.32%
Lunia Capital LP 3,000$448,0009.97%
Evolution Wealth Advisors, LLC 301,742$45,056,0009.66%
Biltmore Wealth Management, LLC 157,102$23,458,0009.39%
Conservest Capital Advisors, Inc. 546,203$81,559,0009.19%
Leicht Financial Planning & Wealth Management, Inc. 96,942$14,980,0009.00%
INNEALTA CAPITAL, LLC 105,798$15,798,0008.85%
View complete list of SELECT SECTOR SPDR TR shareholders